Celldex (CLDX) Therapeutics announced that Denice Torres has been elected to the company’s Board of Directors. Torres currently serves as Chief Executive Officer of The Ignited Company, a Pennsylvania-based consulting firm she founded in 2017
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLDX:
- Celldex’s Strategic Advancements and Promising Pipeline Drive Buy Rating
- Celldex Therapeutics Reports Increased Losses Amid R&D Expansion
- Celldex Therapeutics: Promising Pipeline and Strategic Developments Justify Buy Rating
- Celldex’s Strategic Advancements and Promising Clinical Developments Drive Buy Rating
- Celldex price target lowered to $38 from $44 at UBS
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue